Skip to main content
. 2019 Feb 18;9:2199. doi: 10.1038/s41598-018-37240-z

Figure 5.

Figure 5

Kaplan-Meier survival comparisons of cases with ALK mutation vs non-ALK mutation cases. Kaplan-Meier (overall survival) analysis according to the presence or absence of somatic ALK aberrations in 105 neuroblastoma tumours (a) ALK mutated versus non-ALK mutated cases (b) OS according to MYCN and ALK status (MYCN amplification vs. no amplification; ALK alteration versus no alteration). ALK mutational status does not add prognostic information to the independent clinical parameter MYCN status. Pos, positive for ALK alteration (ALK mutations and/or amplification). Wt, wildtype. OS, overall survival.